1 |
IFNG
| [6] TGF-beta signaling pathway TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis | D04242
D04242
|
Fontolizumab
| [1] 46 46 |
2 |
IFNG
| [6] TGF-beta signaling pathway TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis | D11120
D11120
|
Emapalumab
| [2] 49 49, 107 |
3 |
SMAD7
| [1] TGF-beta signaling pathway TGF-beta signaling pathway | D10956
D10956
|
Mongersen
| [2] 96 96, 97 |
4 |
RGMA
| [1] TGF-beta signaling pathway TGF-beta signaling pathway | D11355
D11355
|
Elezanumab
| [1] 13 13 |
5 |
ROCK1
| [4] Vascular smooth muscle contraction Vascular smooth muscle contraction, TGF-beta signaling pathway, Tight junction, Yersinia infection | D07941
D07941
|
Fasudil
| [4] 2 2, 5, 7, 51 |
6 |
BMPR2
| [1] TGF-beta signaling pathway TGF-beta signaling pathway | D03779
D03779
|
Dibotermin alfa
| [1] 34 34 |
7 |
TGFB1
| [4] TGF-beta signaling pathway TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis | D09620
D09620
|
Fresolimumab
| [4] 51 51, 85, 222, 274 |
8 |
TGFB2
| [3] TGF-beta signaling pathway TGF-beta signaling pathway, Toxoplasmosis, Tuberculosis | D09620
D09620
|
Fresolimumab
| [4] 51 51, 85, 222, 274 |
9 |
TGFB3
| [3] TGF-beta signaling pathway TGF-beta signaling pathway, Toxoplasmosis, Tuberculosis | D09620
D09620
|
Fresolimumab
| [4] 51 51, 85, 222, 274 |
10 |
TNF
| [9] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D00742
D00742
|
Etanercept
| [17] 15 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285, 298 |
11 |
TNF
| [9] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D00754
D00754
|
Thalidomide
| [20] 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 |
12 |
TNF
| [9] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D01583
D01583
|
Pirfenidone
| [11] 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
13 |
TNF
| [9] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D02597
D02597
|
Adalimumab
| [18] 19 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 151, 160, 164, 222, 226, 269, 270, 271 |
14 |
TNF
| [9] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D02598
D02598
|
Infliximab
| [27] 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 |
15 |
TNF
| [9] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D03441
D03441
|
Certolizumab pegol
| [8] 37 37, 46, 49, 96, 97, 107, 226, 271 |
16 |
TNF
| [9] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D04358
D04358
|
Golimumab
| [8] 46 46, 56, 84, 96, 97, 107, 270, 271 |
17 |
TNF
| [9] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D04687
D04687
|
Lenalidomide
| [8] 16 16, 26, 28, 34, 49, 284, 300, 331 |
18 |
TNF
| [9] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D05393
D05393
|
Pegsunercept
| [1] 46 46 |
19 |
TNF
| [9] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D08976
D08976
|
Pomalidomide
| [6] 28 28, 34, 51, 85, 227, 331 |
20 |
TNF
| [9] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, TGF-beta signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Yersinia infection, Toxoplasmosis, Tuberculosis | D09944
D09944
|
Ozoralizumab
| [1] 46 46 |
21 |
ACVR2A
| [1] TGF-beta signaling pathway TGF-beta signaling pathway | D09670
D09670
|
Sotatercept
| [2] 86 86, 284 |
22 |
ACVR2A
| [1] TGF-beta signaling pathway TGF-beta signaling pathway | D10620
D10620
|
Bimagrumab
| [1] 15 15 |
23 |
ACVR2B
| [1] TGF-beta signaling pathway TGF-beta signaling pathway | D10620
D10620
|
Bimagrumab
| [1] 15 15 |